Shopping Cart 0
Cart Subtotal
AED 0

Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 27525

Details

Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017" provides an overview of Embolization and Coiling Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Embolization and Coiling Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Embolization and Coiling Devices under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Embolization and Coiling Devices and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Embolization and Coiling Devices under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Embolization and Coiling Devices Overview 7

3 Products under Development 8

3.1 Embolization and Coiling Devices-Pipeline Products by Stage of Development 8

3.2 Embolization and Coiling Devices-Pipeline Products by Segment 9

3.3 Embolization and Coiling Devices-Pipeline Products by Territory 10

3.4 Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11

3.5 Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12

3.6 Embolization and Coiling Devices-Ongoing Clinical Trials 13

4 Embolization and Coiling Devices-Pipeline Products under Development by Companies 14

4.1 Embolization and Coiling Devices Companies-Pipeline Products by Stage of Development 14

4.2 Embolization and Coiling Devices-Pipeline Products by Stage of Development 15

5 Embolization and Coiling Devices Companies and Product Overview 16

5.1 Aneuclose LLC Company Overview 16

5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Avantec Vascular Corporation Company Overview 17

5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 BioCure, Inc. Company Overview 18

5.3.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Collagen Matrix Inc Company Overview 19

5.4.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 DePuy Synthes Inc Company Overview 20

5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Insera Therapeutics, LLC Company Overview 21

5.6.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Medtronic plc Company Overview 22

5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 MicroPort Scientific Corp Company Overview 26

5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 MicroVention, Inc. Company Overview 29

5.9.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 MiVi Neuroscience, LLC Company Overview 35

5.10.1 MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 Neuravi Ltd Company Overview 36

5.11.1 Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Shape Memory Therapeutics, Inc. Company Overview 40

5.12.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

5.13 Taewoong Medical Co Ltd Company Overview 41

5.13.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 Terumo Corp Company Overview 43

5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

5.15 University of California Los Angeles Company Overview 44

5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 University of Minnesota Company Overview 45

5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 University of Wisconsin Madison Company Overview 46

5.17.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Valor Medical Inc Company Overview 47

5.18.1 Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.19 Vascular Solutions Inc Company Overview 48

5.19.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

6 Embolization and Coiling Devices- Recent Developments 49

6.1 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 49

6.2 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 49

6.3 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 50

6.4 Apr 25, 2017: Stryker reports first quarter 2017 results 51

6.5 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 52

6.6 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 53

6.7 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 55

6.8 Mar 30, 2017: MPSC Announces 2016 Annual Results 57

6.9 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study 58

6.10 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 59

6.11 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke 60

6.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 61

6.13 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 64

6.14 Feb 09, 2017: Terumo Announces Change of Executive Officers 65

6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 66

6.16 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67

6.17 Jan 31, 2017: Terumo Opens a Branch in Yangon 68

6.18 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 68

6.19 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 70

6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 72

6.21 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 74

6.22 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors 75

6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 75

6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 76

6.25 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 79

6.26 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 79

6.27 Nov 15, 2016: Penumbra Announces Resignation of Board Member 80

6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 80

6.29 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 81

6.30 Oct 27, 2016: Stryker reports third quarter 2016 results 81

6.31 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 83

6.32 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 84

6.33 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 85

6.34 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 88

6.35 Oct 14, 2016: Medtronic Announces Voluntary Recall of Its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters 89

6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 90

6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 91

6.38 Sep 07, 2016: Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke 92

6.39 Aug 30, 2016: MPSC Announces 2016 Interim Results 93

6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 94

6.41 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 97

6.42 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 97

6.43 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 99

6.44 Jul 26, 2016: Merit Medical Announces Appointment of New Director 100

6.45 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 100

6.46 Jul 25, 2016: Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever 103

6.47 Jul 21, 2016: Stryker reports second quarter 2016 results 104

6.48 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 105

6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 107

6.50 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 107

6.51 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing 108

6.52 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 108

6.53 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 109

6.54 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 109

6.55 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 110

7 Appendix 114

7.1 Methodology 114

7.2 About GlobalData 117

7.3 Contact Us 117

7.4 Disclaimer 117


List Of Figure

1.2 List of Figures

Figure 1: Embolization and Coiling Devices-Pipeline Products by Stage of Development 8

Figure 2: Embolization and Coiling Devices-Pipeline Products by Segment 9

Figure 3: Embolization and Coiling Devices-Pipeline Products by Territory 10

Figure 4: Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11

Figure 5: Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12

Figure 6: Embolization and Coiling Devices-Ongoing Clinical Trials 13


List Of Table

1.1 List of Tables

Table 1: Embolization and Coiling Devices-Pipeline Products by Stage of Development 8

Table 2: Embolization and Coiling Devices-Pipeline Products by Segment 9

Table 3: Embolization and Coiling Devices-Pipeline Products by Territory 10

Table 4: Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11

Table 5: Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12

Table 6: Embolization and Coiling Devices-Ongoing Clinical Trials 13

Table 7: Embolization and Coiling Devices Companies-Pipeline Products by Stage of Development 14

Table 8: Embolization and Coiling Devices-Pipeline Products by Stage of Development 15

Table 9: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 10: Janjua Aneurysm Net-Product Status 16

Table 11: Janjua Aneurysm Net-Product Description 16

Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17

Table 13: Endovascular Embolization Device-Product Status 17

Table 14: Endovascular Embolization Device-Product Description 17

Table 15: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

Table 16: GelCoil-Product Status 18

Table 17: GelCoil-Product Description 18

Table 18: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 19: Collagen-based Coils-Product Status 19

Table 20: Collagen-based Coils-Product Description 19

Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 22: Liquid Embolic System-Product Status 20

Table 23: Liquid Embolic System-Product Description 20

Table 24: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 25: SHELTER-Product Status 21

Table 26: SHELTER-Product Description 21

Table 27: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 28: Medina Embolization Device-Product Status 22

Table 29: Medina Embolization Device-Product Description 22

Table 30: UNO Neurovascular Embolization System-Product Status 23

Table 31: UNO Neurovascular Embolization System-Product Description 23

Table 32: Medtronic plc-Ongoing Clinical Trials Overview 24

Table 33: Medina Embolization Device-Medina Embolization Device in Neurovascular Aneurysms Study-A Post Market Clinical Follow-up Study: The MEDINA Study 25

Table 34: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 35: Embolization Coils-Product Status 26

Table 36: Embolization Coils-Product Description 26

Table 37: MicroPort Scientific Corp-Ongoing Clinical Trials Overview 27

Table 38: Embolization Coils-Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 28

Table 39: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 40: Advanced Coil-Product Status 29

Table 41: Advanced Coil-Product Description 29

Table 42: Advanced WEB Aneurysm Embolization Device-Product Status 30

Table 43: Advanced WEB Aneurysm Embolization Device-Product Description 30

Table 44: WEB Aneurysm Embolization System-Product Status 30

Table 45: WEB Aneurysm Embolization System-Product Description 31

Table 46: MicroVention, Inc.-Ongoing Clinical Trials Overview 32

Table 47: WEB Aneurysm Embolization System-Clinical Assessment of Web Device in Ruptured Aneurysms 33

Table 48: WEB Aneurysm Embolization System-CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS 33

Table 49: WEB Aneurysm Embolization System-The WEB Intrasaccular Therapy Study (WEB-IT) 33

Table 50: WEB Aneurysm Embolization System-WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 34

Table 51: WEB Aneurysm Embolization System-WEB French Observatory 34

Table 52: MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 53: Neuronet-Product Status 35

Table 54: Neuronet-Product Description 35

Table 55: Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 56: EmboTrap II Revascularization Device-Product Status 36

Table 57: EmboTrap II Revascularization Device-Product Description 36

Table 58: EmboTrap Revascularization Device-Product Status 37

Table 59: EmboTrap Revascularization Device-Product Description 37

Table 60: Neuravi Ltd-Ongoing Clinical Trials Overview 38

Table 61: EmboTrap Revascularization Device-A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke with EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device 39

Table 62: EmboTrap Revascularization Device-ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap) Study 39

Table 63: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 64: Neurovascular Embolization System-Product Status 40

Table 65: Neurovascular Embolization System-Product Description 40

Table 66: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Table 67: K3 Platium Coil-Product Status 41

Table 68: K3 Platium Coil-Product Description 42

Table 69: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

Table 70: VFC /Hydrofill Coil-Product Status 43

Table 71: VFC /Hydrofill Coil-Product Description 43

Table 72: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44

Table 73: Bioactive Endovascular Coil-Product Status 44

Table 74: Bioactive Endovascular Coil-Product Description 44

Table 75: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45

Table 76: Vascular Embolization Catheter-Product Status 45

Table 77: Vascular Embolization Catheter-Product Description 45

Table 78: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46

Table 79: Bioactive Endovascular Device-Product Status 46

Table 80: Bioactive Endovascular Device-Product Description 46

Table 81: Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 82: Neucrylate AN-Product Status 47

Table 83: Neucrylate AN-Product Description 47

Table 84: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 85: Embolization Device-Product Status 48

Table 86: Embolization Device-Product Description 48

Table 87: Glossary 116

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Aneuclose LLC, Janjua Aneurysm Net; Avantec Vascular Corporation, Endovascular Embolization Device; BioCure, Inc., GelCoil; Collagen Matrix Inc, Collagen-based Coils; DePuy Synthes Inc, Liquid Embolic System; Insera Therapeutics, LLC, SHELTER; Medtronic plc, Medina Embolization Device; Medtronic plc, UNO Neurovascular Embolization System; MicroPort Scientific Corp, Embolization Coils; MicroVention, Inc., Advanced Coil; MicroVention, Inc., Advanced WEB Aneurysm Embolization Device; MicroVention, Inc., WEB Aneurysm Embolization System; MiVi Neuroscience, LLC, Neuronet; Neuravi Ltd, EmboTrap II Revascularization Device; Neuravi Ltd, EmboTrap Revascularization Device; Shape Memory Therapeutics, Inc., Neurovascular Embolization System; Taewoong Medical Co Ltd, K3 Platium Coil; Terumo Corp, VFC /Hydrofill Coil; University of California Los Angeles, Bioactive Endovascular Coil; University of Minnesota, Vascular Embolization Catheter; University of Wisconsin Madison, Bioactive Endovascular Device; Valor Medical Inc, Neucrylate AN; Vascular Solutions Inc, Embolization Device


Companies

Aneuclose LLC, Avantec Vascular Corporation, BioCure, Inc., Collagen Matrix Inc, DePuy Synthes Inc, Insera Therapeutics, LLC, Medtronic plc, MicroPort Scientific Corp, MicroVention, Inc., MiVi Neuroscience, LLC, Neuravi Ltd, Shape Memory Therapeutics, Inc., Taewoong Medical Co Ltd, Terumo Corp, University of California Los Angeles, University of Minnesota, University of Wisconsin Madison, Valor Medical Inc, Vascular Solutions Inc

Company Profile

Company Profile Title

Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Embolization and Coiling Devices-Medical Devices Pipeline Assessment, 2017" provides an overview of Embolization and Coiling Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Embolization and Coiling Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Embolization and Coiling Devices under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Embolization and Coiling Devices and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Embolization and Coiling Devices under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Embolization and Coiling Devices Overview 7

3 Products under Development 8

3.1 Embolization and Coiling Devices-Pipeline Products by Stage of Development 8

3.2 Embolization and Coiling Devices-Pipeline Products by Segment 9

3.3 Embolization and Coiling Devices-Pipeline Products by Territory 10

3.4 Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11

3.5 Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12

3.6 Embolization and Coiling Devices-Ongoing Clinical Trials 13

4 Embolization and Coiling Devices-Pipeline Products under Development by Companies 14

4.1 Embolization and Coiling Devices Companies-Pipeline Products by Stage of Development 14

4.2 Embolization and Coiling Devices-Pipeline Products by Stage of Development 15

5 Embolization and Coiling Devices Companies and Product Overview 16

5.1 Aneuclose LLC Company Overview 16

5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Avantec Vascular Corporation Company Overview 17

5.2.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 BioCure, Inc. Company Overview 18

5.3.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Collagen Matrix Inc Company Overview 19

5.4.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 DePuy Synthes Inc Company Overview 20

5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Insera Therapeutics, LLC Company Overview 21

5.6.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Medtronic plc Company Overview 22

5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 MicroPort Scientific Corp Company Overview 26

5.8.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 MicroVention, Inc. Company Overview 29

5.9.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 MiVi Neuroscience, LLC Company Overview 35

5.10.1 MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 Neuravi Ltd Company Overview 36

5.11.1 Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Shape Memory Therapeutics, Inc. Company Overview 40

5.12.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

5.13 Taewoong Medical Co Ltd Company Overview 41

5.13.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 Terumo Corp Company Overview 43

5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

5.15 University of California Los Angeles Company Overview 44

5.15.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 University of Minnesota Company Overview 45

5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 University of Wisconsin Madison Company Overview 46

5.17.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Valor Medical Inc Company Overview 47

5.18.1 Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.19 Vascular Solutions Inc Company Overview 48

5.19.1 Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

6 Embolization and Coiling Devices- Recent Developments 49

6.1 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 49

6.2 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 49

6.3 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 50

6.4 Apr 25, 2017: Stryker reports first quarter 2017 results 51

6.5 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 52

6.6 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 53

6.7 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 55

6.8 Mar 30, 2017: MPSC Announces 2016 Annual Results 57

6.9 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study 58

6.10 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 59

6.11 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke 60

6.12 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 61

6.13 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 64

6.14 Feb 09, 2017: Terumo Announces Change of Executive Officers 65

6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 66

6.16 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67

6.17 Jan 31, 2017: Terumo Opens a Branch in Yangon 68

6.18 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 68

6.19 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 70

6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 72

6.21 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 74

6.22 Dec 19, 2016: Penumbra Appoints Thomas C. Wilder to its Board of Directors 75

6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 75

6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 76

6.25 Nov 22, 2016: Collagen Matrix Names Oystein Valberg as Chief Financial Officer 79

6.26 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 79

6.27 Nov 15, 2016: Penumbra Announces Resignation of Board Member 80

6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 80

6.29 Nov 03, 2016: Penumbra Reports Third Quarter 2016 Financial Results 81

6.30 Oct 27, 2016: Stryker reports third quarter 2016 results 81

6.31 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 83

6.32 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 84

6.33 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 85

6.34 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 88

6.35 Oct 14, 2016: Medtronic Announces Voluntary Recall of Its Pipeline Embolization Device, Alligator Retrieval Device, X-Celerator Hydrophilic Guidewire, Ultraflow and Marathon Flow Directed Micro Catheters 89

6.36 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 90

6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 91

6.38 Sep 07, 2016: Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke 92

6.39 Aug 30, 2016: MPSC Announces 2016 Interim Results 93

6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 94

6.41 Aug 09, 2016: Penumbra Reports Second Quarter 2016 Financial Results 97

6.42 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 97

6.43 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 99

6.44 Jul 26, 2016: Merit Medical Announces Appointment of New Director 100

6.45 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 100

6.46 Jul 25, 2016: Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever 103

6.47 Jul 21, 2016: Stryker reports second quarter 2016 results 104

6.48 Jul 19, 2016: Johnson & Johnson Reports 2016 Second-Quarter Results 105

6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 107

6.50 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 107

6.51 Jun 24, 2016: Collagen Matrix Names Bill Messer as Vice President, Sales and Marketing 108

6.52 Jun 22, 2016: Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations 108

6.53 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 109

6.54 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 109

6.55 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 110

7 Appendix 114

7.1 Methodology 114

7.2 About GlobalData 117

7.3 Contact Us 117

7.4 Disclaimer 117


List Of Figure

1.2 List of Figures

Figure 1: Embolization and Coiling Devices-Pipeline Products by Stage of Development 8

Figure 2: Embolization and Coiling Devices-Pipeline Products by Segment 9

Figure 3: Embolization and Coiling Devices-Pipeline Products by Territory 10

Figure 4: Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11

Figure 5: Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12

Figure 6: Embolization and Coiling Devices-Ongoing Clinical Trials 13


List Of Table

1.1 List of Tables

Table 1: Embolization and Coiling Devices-Pipeline Products by Stage of Development 8

Table 2: Embolization and Coiling Devices-Pipeline Products by Segment 9

Table 3: Embolization and Coiling Devices-Pipeline Products by Territory 10

Table 4: Embolization and Coiling Devices-Pipeline Products by Regulatory Path 11

Table 5: Embolization and Coiling Devices-Pipeline Products by Estimated Approval Date 12

Table 6: Embolization and Coiling Devices-Ongoing Clinical Trials 13

Table 7: Embolization and Coiling Devices Companies-Pipeline Products by Stage of Development 14

Table 8: Embolization and Coiling Devices-Pipeline Products by Stage of Development 15

Table 9: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 16

Table 10: Janjua Aneurysm Net-Product Status 16

Table 11: Janjua Aneurysm Net-Product Description 16

Table 12: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 17

Table 13: Endovascular Embolization Device-Product Status 17

Table 14: Endovascular Embolization Device-Product Description 17

Table 15: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

Table 16: GelCoil-Product Status 18

Table 17: GelCoil-Product Description 18

Table 18: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 19: Collagen-based Coils-Product Status 19

Table 20: Collagen-based Coils-Product Description 19

Table 21: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 20

Table 22: Liquid Embolic System-Product Status 20

Table 23: Liquid Embolic System-Product Description 20

Table 24: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 25: SHELTER-Product Status 21

Table 26: SHELTER-Product Description 21

Table 27: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 28: Medina Embolization Device-Product Status 22

Table 29: Medina Embolization Device-Product Description 22

Table 30: UNO Neurovascular Embolization System-Product Status 23

Table 31: UNO Neurovascular Embolization System-Product Description 23

Table 32: Medtronic plc-Ongoing Clinical Trials Overview 24

Table 33: Medina Embolization Device-Medina Embolization Device in Neurovascular Aneurysms Study-A Post Market Clinical Follow-up Study: The MEDINA Study 25

Table 34: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 26

Table 35: Embolization Coils-Product Status 26

Table 36: Embolization Coils-Product Description 26

Table 37: MicroPort Scientific Corp-Ongoing Clinical Trials Overview 27

Table 38: Embolization Coils-Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 28

Table 39: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 40: Advanced Coil-Product Status 29

Table 41: Advanced Coil-Product Description 29

Table 42: Advanced WEB Aneurysm Embolization Device-Product Status 30

Table 43: Advanced WEB Aneurysm Embolization Device-Product Description 30

Table 44: WEB Aneurysm Embolization System-Product Status 30

Table 45: WEB Aneurysm Embolization System-Product Description 31

Table 46: MicroVention, Inc.-Ongoing Clinical Trials Overview 32

Table 47: WEB Aneurysm Embolization System-Clinical Assessment of Web Device in Ruptured Aneurysms 33

Table 48: WEB Aneurysm Embolization System-CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS 33

Table 49: WEB Aneurysm Embolization System-The WEB Intrasaccular Therapy Study (WEB-IT) 33

Table 50: WEB Aneurysm Embolization System-WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 34

Table 51: WEB Aneurysm Embolization System-WEB French Observatory 34

Table 52: MiVi Neuroscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 53: Neuronet-Product Status 35

Table 54: Neuronet-Product Description 35

Table 55: Neuravi Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 56: EmboTrap II Revascularization Device-Product Status 36

Table 57: EmboTrap II Revascularization Device-Product Description 36

Table 58: EmboTrap Revascularization Device-Product Status 37

Table 59: EmboTrap Revascularization Device-Product Description 37

Table 60: Neuravi Ltd-Ongoing Clinical Trials Overview 38

Table 61: EmboTrap Revascularization Device-A.R.I.S.E. Analysis of Revascularisation in Ischemic Stroke with EmboTrap: Post Marketing Observational Study of CE Marked EmboTrap Mechanical Thrombectomy Device 39

Table 62: EmboTrap Revascularization Device-ARISE II (Analysis of Revascularization in Ischemic Stroke with EmboTrap) Study 39

Table 63: Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 64: Neurovascular Embolization System-Product Status 40

Table 65: Neurovascular Embolization System-Product Description 40

Table 66: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Table 67: K3 Platium Coil-Product Status 41

Table 68: K3 Platium Coil-Product Description 42

Table 69: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 43

Table 70: VFC /Hydrofill Coil-Product Status 43

Table 71: VFC /Hydrofill Coil-Product Description 43

Table 72: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 44

Table 73: Bioactive Endovascular Coil-Product Status 44

Table 74: Bioactive Endovascular Coil-Product Description 44

Table 75: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 45

Table 76: Vascular Embolization Catheter-Product Status 45

Table 77: Vascular Embolization Catheter-Product Description 45

Table 78: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 46

Table 79: Bioactive Endovascular Device-Product Status 46

Table 80: Bioactive Endovascular Device-Product Description 46

Table 81: Valor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Table 82: Neucrylate AN-Product Status 47

Table 83: Neucrylate AN-Product Description 47

Table 84: Vascular Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 85: Embolization Device-Product Status 48

Table 86: Embolization Device-Product Description 48

Table 87: Glossary 116

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Aneuclose LLC, Janjua Aneurysm Net; Avantec Vascular Corporation, Endovascular Embolization Device; BioCure, Inc., GelCoil; Collagen Matrix Inc, Collagen-based Coils; DePuy Synthes Inc, Liquid Embolic System; Insera Therapeutics, LLC, SHELTER; Medtronic plc, Medina Embolization Device; Medtronic plc, UNO Neurovascular Embolization System; MicroPort Scientific Corp, Embolization Coils; MicroVention, Inc., Advanced Coil; MicroVention, Inc., Advanced WEB Aneurysm Embolization Device; MicroVention, Inc., WEB Aneurysm Embolization System; MiVi Neuroscience, LLC, Neuronet; Neuravi Ltd, EmboTrap II Revascularization Device; Neuravi Ltd, EmboTrap Revascularization Device; Shape Memory Therapeutics, Inc., Neurovascular Embolization System; Taewoong Medical Co Ltd, K3 Platium Coil; Terumo Corp, VFC /Hydrofill Coil; University of California Los Angeles, Bioactive Endovascular Coil; University of Minnesota, Vascular Embolization Catheter; University of Wisconsin Madison, Bioactive Endovascular Device; Valor Medical Inc, Neucrylate AN; Vascular Solutions Inc, Embolization Device


Companies

Aneuclose LLC, Avantec Vascular Corporation, BioCure, Inc., Collagen Matrix Inc, DePuy Synthes Inc, Insera Therapeutics, LLC, Medtronic plc, MicroPort Scientific Corp, MicroVention, Inc., MiVi Neuroscience, LLC, Neuravi Ltd, Shape Memory Therapeutics, Inc., Taewoong Medical Co Ltd, Terumo Corp, University of California Los Angeles, University of Minnesota, University of Wisconsin Madison, Valor Medical Inc, Vascular Solutions Inc